CLNN (STOCKS)
Clene Inc. Common Stock
$5.770000
-0.070000 (-1.20%)
Prev close: $5.840000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert Dee Etherington
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $74.11M
- Employees
- 76
- P/E (TTM)
- -1.80
- P/B (TTM)
- -3.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.27 | $-0.65 | +0.3794 | +58.42% |
|
Dec 2025 (Q4)
|
$-0.88 | $-0.60 | -0.2823 | -47.23% |
|
Sep 2025 (Q3)
|
$-0.85 | $-0.59 | -0.2584 | -43.68% |
|
Jun 2025 (Q2)
|
$-0.78 | $-0.48 | -0.2972 | -61.56% |
Financial Statements
| Assets | $21.67M |
| Current Assets | $13.02M |
| Cash | $5.90M |
| Inventory | $54.00K |
| Other Current Assets | $7.07M |
| Noncurrent Assets | $8.64M |
| Liabilities | $40.47M |
| Current Liabilities | $6.73M |
| Accounts Payable | $1.31M |
| Other Current Liabilities | $5.42M |
| Noncurrent Liabilities | $33.74M |
| Long-term Debt | $17.70M |
| Other Non-current Liabilities | $16.05M |
| Equity | -$18.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$18.81M |
| Liabilities And Equity | $21.67M |